PENGUIN (PENGUIN) 24-hour volatility at 46.3%: Whale buying drives low-liquidity surge
Bitget Pulse2026/04/04 16:15Volatility Overview
In the past 24 hours, PENGUIN's price reached a low of $0.00246 and a high of $0.00360, currently at $0.00358—with an amplitude as high as 46.3%, indicating significant volatility. The 24-hour trading volume is approximately $1.85 million, with a market capitalization around $2.6 million, suggesting relatively low liquidity.
Brief Analysis of Causes for Price Movements
- On-chain monitoring shows several large whale purchases in the past 24 hours, such as single transactions of 12.11 SOL (which currently drove market cap) and 14.99 SOL, directly triggering a price rebound from the low.
- This token is a meme coin on Solana (CA: 8Jx8AAHj86wbQgUTjGuj6GTTL5Ps3cqxKRTvpaJApump). Its low liquidity amplifies the influence of whale movements, and there are no official announcements or mainstream news events.
Market Views & Outlook
Community discussions reveal a generally cautious yet optimistic sentiment, with some users bullish on its “next 100 million potential.” However, trading volume is only at the $50k level. Risks include market manipulation due to low volume and potential rug pulls; analysts recommend closely monitoring whale activity and avoiding buying at highs.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Record High Monthly Active Users Can't Hide Risks: Pinterest (PINS.US) Q3 Revenue and Profit Both Miss Expectations, Q4 Guidance Weak, Shares Drop Over 10% After Hours
Pinterest (PINS.US), the image-based social networking and shopping platform, released its Q3 2026 financial report on Thursday, October 29 local time. Although global monthly active users (MAU) reached a historic high of 661 million and net sales achieved double-digit growth, both the company's revenue and adjusted profit for the quarter fell short of Wall Street expectations.
Core business achieves fastest growth in over a decade! Gilead (GILD.US) Q3 is a mix of good and bad news: Raises full-year sales guidance but Biktarvy will face a 38% price cut pressure from U.S. Medicare
On October 29th (Thursday) local time, US biopharmaceutical giant Gilead Sciences (GILD.US) released its financial report for the third quarter of 2026. Driven by double-digit growth in its flagship HIV drug portfolio, the company's product sales in the quarter increased by 13% year-over-year to $8.3 billion, surpassing market expectations.
Bank of Japan to leave interest rates steady at 1.25%
U.S. mortgage rates fall for two consecutive weeks but struggle to boost market; home sales prices decline for the first time in over three years
U.S. mortgage rates have declined for the second consecutive week but remain above 7%, failing to effectively boost the persistently sluggish housing market.
Crypto prices
More
